← FDA DRUG APPROVALS

FDA ANDA · ANDA065024

GENTAMICIN SULFATE

Sponsor: FERA PHARMS LLC

APPLICATION
ANDA065024
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-30
LATEST ACTION
2004-07-30
ROUTE
OPHTHALMIC
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

GENTAMICIN SULFATEPrescription
GENTAMICIN SULFATE EQ 0.3% BASE · OINTMENT · OPHTHALMIC

Approval history

2004-07-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →